AstraZeneca ChAdOx1-S COVID-19

TGA

18 March 2021 - The TGA is closely reviewing reports of anaphylaxis after four cases were reported following the AstraZeneca ChAdOx1-S vaccine in the past 2 days in Queensland.

The Australian Technical Advisory Group on Immunisation (ATAGI) advice emphasises that people without a previous history of specific or severe allergy should be observed post vaccination for the recommended 15 minute period.

Read TGA News

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Australia , Vaccine , Safety , COVID-19